References
- Heim S, Mitelman F. Cancer Cytogenetics2nd edition. Wiley‐Liss, Inc, NY 1995
- Berger R, Bernheim A, Daniel M T, Flandrin G. t(15;17) in a promyelocytic form of chronic myeloid leukemia blast crisis. Cancer Genet. Cytogenet. 1983; 8: 149–152
- Lai J L, Fenaux P, Zandecki M, Savary J B, Estienne M H, Jouet J P, Bauters F, Deminatti M. Promyelocytic blast crisis of Philadelphia‐positve thrombocythemia with translocations (9;22) and (15,17). Cancer Genet. Cytogenet 1987; 29: 311–314
- Xue Y, Guo Y, Lu D, Gu J, Lu D, Gong J, Wang M, Shu W, Lin B. A case of basophilic leukemia bearing simultaneous translocations (t(8;21) and t(9;22). Cancer Genet. Cytogenet. 1991; 51: 215–221
- Charrin C, Ritouet D, Campos L, Devaux Y, Archimbaud E, Fraisse J, Fiere D, Germain D. Association of t(15;17) and t(8;21) in the initial phase of an acute promyelocytic leukemia. Cancer Genet. Cytogenet. 1992; 56: 177–180
- Ferro M T, Steegman J L, Escribano L, Heiurichs B, Parada L, Garcia‐Sagredo J M, Resino M, Cabello P, San Roman C. Ph‐positive chronic mueloid leukemia with t(8;21)(q22;q22) in blastic crisis. Cancer Genet. Cytogenet. 1992; 58: 96–99
- Movafagh A, Varma N, Varma S. Co‐expression of two FAB‐specific chromosome changes, t(15;17) and t(8;21), in a case of acute promyelocytic leukemia. Ann. Hematol. 1996; 72: 375–377
- Najfeld V, Geller M, Troy K, Scalise A. Acquisition of the Ph chromosome and BCR‐ABL fusion product in AML‐M2 and t(8;21) leukemia: cytogenetic and FISH evidence for a late event. Leukemia 1998; 12: 517–519
- Paskulin G A, Philips G, Morgan R, Sandberg A, Richkind K, Borovik C, McGavran L, Rabinovich N, Dietz‐Band J, Erickson P, Drabkin H, Varella‐Garcia M. Pre‐clinical evaluation of probes to detect t(8;21) AML minimal residual disease by fluorescence in situ hybridization. Genes Chrom Cancer 1998; 21: 144–151
- Di Bona E, Montaldi A, Guercini N, Rossi V, Luciano A, Biondi A, Rodeghiero F. A (15;17) translocation not associated with acute promyelocytic leukaemia. Br. J. Haematol. 1996; 95: 706–709